Publication date: Available online 11 November 2026 Source: American Heart Journal Author(s): Daniel Burkhoff, Avi Fischer, Steven J. Evans, Yuval H. Mika, Angela Stagg, David E. Kandzari, Andrea M. Russo, Raymond R. Townsend, Béla Merkely, JoAnn Lindenfeld, Charles Love, Felix Mahfoud, Gheorghe Doros, Vivek Reddy, BACKBEAT Investigators
Rationale and Design of the BradycArdia paCemaKer with AV interval modulation for Blood prEssure treAtmenT (BACKBEAT) Pivotal Trial. // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326003145?dgcid=rss_sd_all
Rationale and Design of the BradycArdia paCemaKer with AV interval modulation for Blood prEssure treAtmenT (BACKBEAT) Pivotal Trial. American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0002870326003145?dgcid=rss_sd_all
“Rationale and Design of the BradycArdia paCemaKer with AV interval modulation for Blood prEssure treAtmenT (BACKBEAT) Pivotal Trial.” American Journal of Kidney Diseases.
@article{article3301,
title = {Rationale and Design of the BradycArdia paCemaKer with AV interval modulation for Blood prEssure treAtmenT (BACKBEAT) Pivotal Trial},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326003145?dgcid=rss_sd_all}
}